Calypte Biomedical Corp (fka CBMC)

[AxiomOne]

lose/lose deal for Calypte?

How so? These deals are very popular amongst small bio-tech companies that need funding. The shares upfront are a fee for an agreement that could produce upwards of $8 million dollars in funding for the company. This type of funding puts the control in the hands of Calypte and is very flexible. Calypte has the ability to sell stock when it feels necessary and allows them to use the proceeds as needed. The stock will never be sold at a reduced/discounted price to Fusion, but sold at current market price. There is still obvious risk involved for Fusion and is really a must need (and therefore will say 'win') for the Company. Is it a win for shareholders though? Time will tell that....more time (seems like a never ending story here)

BTW - I thought you were leaving the message boards alone for while? Couldn't keep away huh? So sad...We should all have an intervention for you.